跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
蘇 佳沂
助理教授
生醫光電研究所
電子郵件
cysu
nycu.edu
tw
h-index
h10-index
h5-index
1017
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
862
引文
19
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
102
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2011
2023
每年研究成果
概覽
指紋
網路
研究成果
(33)
類似的個人檔案
(2)
指紋
查看啟用 Chia-Yi Su 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Activin
11%
Aldolase
21%
Autophagy
12%
Breast Cancer Cells
13%
Cancer Metastasis
27%
Cancer Progression
17%
Catenin
12%
Cell Growth
12%
Cell Migration
28%
Cell Proliferation
13%
Colorectal Cancer
12%
Colorectal Cancer Patients
12%
Dysregulation
22%
Epithelial-mesenchymal Transition
15%
Gene Signature
13%
Head-and-neck Cancer
13%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
42%
Heat Shock Protein 90 (Hsp90)
22%
Knockdown
12%
Leukocyte Cell-derived Chemotaxin 2 (LECT2)
11%
Lung Adenocarcinoma
35%
Lung Cancer
31%
Lung Cancer Cells
17%
Lung Cancer Progression
15%
Lung Metastasis
28%
Lymph Node Metastasis
12%
Matrix metalloproteinase-9 (MMP-9)
21%
Metastasis
56%
Metastatic Progression
12%
Mutant EGFR
11%
Non-small Cell Lung Cancer (NSCLC)
22%
Non-small Cell Lung Cancer Cells
15%
Non-small Cell Lung Cancer Patients
14%
Oral Cancer
11%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
23%
Overexpression
13%
Poor Prognosis
87%
Prognosis Marker
37%
Prognostic Effect
12%
Prognostic Marker
13%
Prognostic Role
13%
Pyruvate Kinase M2 (PKM2)
22%
Renal Cell Carcinoma Metastasis
11%
Runt-related Transcription Factor 2 (Runx2)
22%
Smad Signaling
11%
Tumor
19%
Tumor Cells
13%
Tumor Microenvironment
14%
Tumor Spheroids
13%
Vascular Endothelial Growth Factor 165
11%
Medicine and Dentistry
Activin A
11%
Amine Oxidase (Flavin Containing)
11%
Bone Morphogenetic Protein 4
11%
Breast Cancer
15%
Cancer Cell
37%
Cancer Growth
18%
Cancer Types
11%
Carbohydrate Sulfotransferase
11%
Cell Migration
16%
Cell Nucleus DNA
11%
Ceruloplasmin
11%
Clear Cell Renal Cell Carcinoma
11%
Colorectal Carcinoma
22%
Downregulation
23%
Drug Resistance
11%
Epidermal Growth Factor Receptor
12%
Follistatin Related Protein
11%
Fructose Bisphosphate Aldolase
21%
Gelatinase B
20%
Head and Neck Cancer
15%
Head and Neck Squamous Cell Carcinoma
42%
Hypoxia Inducible Factor 1
11%
In Vitro
17%
Iron Balance
11%
Lung Adenocarcinoma
24%
Lung Cancer
71%
Lung Metastasis
11%
Lymph Node Metastasis
12%
Malignant Neoplasm
39%
Melanoma
11%
Mesenchymal-Epithelial Transition
15%
Metastatic Carcinoma
100%
Mouth Squamous Cell Carcinoma
12%
Non Small Cell Lung Cancer
35%
Oncogene
11%
Oral Cancer
11%
Parathyroid Hormone
11%
Programmed Cell Death
11%
Protein Expression
11%
Receptor
12%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Snail
16%
Squamous Cell Carcinoma Cell
13%
Stromal Tumor
11%
Synapsin I
13%
Tumor Invasion
13%
Tumor Microenvironment
11%
Tumor Necrosis Factor Receptor 1
11%
Upregulation
16%
Wheeze
11%
Biochemistry, Genetics and Molecular Biology
Activin
11%
Aldolase
11%
Aldolase A
21%
Angiogenesis
11%
Autophagy
14%
Bone Morphogenetic Protein 4
11%
Cancer Cell
47%
Carcinogenesis
18%
Catenin
12%
Cell Death
22%
Cell Growth
12%
Cell Migration
19%
Cell Proliferation
20%
Colon
19%
Disease Free Survival
16%
Downregulation
27%
Enzyme
18%
Epidermal Growth Factor Receptor
25%
Fructose-Bisphosphate Aldolase
11%
Gelatinase B
20%
Gene Expression
13%
Gene Signature
12%
GTPase
11%
Heat Shock Protein
11%
Huntingtin
11%
Hypoxia Inducible Factor 1
11%
JAG1
11%
Leukocyte
11%
Mesenchymal-Epithelial Transition
26%
Mitochondrion
11%
MMP9
20%
Monoamine Oxidase
11%
Multivariate Analysis
17%
Nuclear DNA
11%
Oncogene
11%
Overall Survival
17%
Phosphorylase
11%
PKM2
11%
Plasminogen Activator Inhibitor-2
11%
Precursor
11%
Protease
11%
Protein Expression
23%
Radiosensitivity
11%
RNA
18%
RUNX2
22%
STAT3
11%
Synapsin I
22%
Tissue Microarray
13%
Upregulation
18%
Vascular Endothelial Growth Factor
11%
